Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors
This study is currently recruiting participants.
Study NCT00672269   Information provided by Rutgers University
First Received: May 2, 2008   Last Updated: February 3, 2009   History of Changes

May 2, 2008
February 3, 2009
April 2008
April 2009   (final data collection date for primary outcome measure)
Mutations in MEN1 and SDHD genes [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00672269 on ClinicalTrials.gov Archive Site
 
 
 
Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors
A Pilot Study to Investigate Germ-Line MEN1 and SDHD Gene Mutation in Familial Cases of Carcinoid Cancer

There is a high incidence among the first degree relatives of the carcinoid patients, indicating the involvement of genetic components in its initiation and pathogenesis.

This proposed pilot study will conduct detailed interviews into the medical, environmental, and family histories and to collect blood specimen to obtain DNA. The Blood specimen and DNA will be processed by the Rutgers University Cell and DNA Repository (RUCDR) to rule out Familial Multiple Endocrine Neoplasia (MEN 1), and succinate dehydrogenase complex, subunit D (SDHD), gene inactivation thought to be associated with different types of carcinoid cancer.

 
Observational
Observational Model:  Case Control
Time Perspective:  Prospective
Carcinoid Neuroendocrine Cancer
 
1
Families with carcinoid in multiple family members
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
25
June 2010
April 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Over the age of 18 years
  2. More than one ,member of a family with a history of biopsy confirmed carcinoid tumor
  3. English speaking
  4. Mentally and emotionally capable of answering questions
  5. Willing and available for study participation
  6. At least one other family member with carcinoid tumor

Exclusion Criteria:

  1. If you are under the age of 18 years,
  2. If you are unable to understand or unable to provide informed consent,
  3. If you have a psychological condition (i.e. depression, anxiety disorder, substance abuse, etc.) which might cause you significant problems in dealing with test results.
Both
12 Years and older
No
Contact: Nancy Gardner, PhD 813-731-0894 gardnern@rutgers.edu
Contact: Changshun Shao, PhD Shao@Biology.Rutgers.Edu
United States
 
NCT00672269
Nancy Gardner PhD Principal Investigator, Rutgers University
08-451
Rutgers University
 
Principal Investigator: Nancy Gardner, PhD Rutgers University
Principal Investigator: Changshun Shao, PhD Rutgers University
Rutgers University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP